Embryonal rhabdomyosarcoma with a der(16)t(1;16) translocation

Cancer Genetics and Cytogenetics

Volumn 174, Issue 1, 2007, Pages 68-73

  Kapels, Kayla M ^a   Nishio, Jun ^a   Zhou, Ming ^a   Qualman, Stephen J ^b   Bridge, Julia A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

ARTICLE; BLADDER; CASE REPORT; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 16Q; CHROMOSOME 19; CHROMOSOME 1Q; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CYTOGENETICS; EMBRYONAL RHABDOMYOSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE LOCUS; GENE REARRANGEMENT; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TUMOR CELL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; HUMANS; INFANT; KARYOTYPING; MALE; RHABDOMYOSARCOMA, EMBRYONAL; TRANSLOCATION, GENETIC;

EID: 33847709078     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.11.013     Document Type: Article

References (36)

1. Parham D.M., and Barr F.G. Embryonal rhabdomyosarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours (2002), IARC Press, Lyon 146-149
2. Anderson J., Gordon A., Pritchard-Jones K., and Shipley J. Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 26 (1999) 275-285
3. Gordon T., McManus A., Anderson J., Min T., Swansbury J., Pritchard-Jones K., Shipley J., and United Kingdom Children's Cancer Study Group; United Kingdom Cancer Cytogenetics Group. Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study. Med Pediatr Oncol 36 (2001) 259-267
4. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated June 2006. Available from http://cgap.nci.nih.gov/Chromosomes/Mitelman.
5. Bridge J.A., Liu J., Weibolt V., Baker K.S., Perry D., Kruger R., Qualman S., Barr F., Sorensen P., Triche T., and Suijkerbuijk R. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an Intergroup Rhabdomyosarcoma study. Genes Chromosomes Cancer 27 (2000) 337-344
6. Bridge J.A., Liu J., Qualman S.J., Suijkerbuijk R., Wenger G., Zhang J., Wan X., Baker K.S., Sorensen P., and Barr F.G. Genomic gains and losses are similar in genetic and histologic subtypes of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33 (2002) 310-321
7. Wang-Wuu S., Soukup S., Ballard E., Gotwals B., and Lampkin B. Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res 48 (1988) 983-987
8. Douglass E.C., Shapiro D.N., Valentine M., Rowe S.T., Carroll A.J., Raney R.B., Ragab A.H., Abella S.M., and Parham D.M. Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 21 (1993) 83-87
9. McManus A.P., Min T., Swansbury G.J., Gusterson B.A., Pinkerton C.R., and Shipley J.M. der(16)t(1;16)(q21;q13) as a secondary change in alveolar rhabdomyosarcoma: a case report and review of the literature. Cancer Genet Cytogenet 87 (1996) 179-181
10. Sandberg A.A., Stone J.F., Czarnecki L., and Cohen J.D. Hematologic masquerade of rhabdomyosarcoma. Am J Hematol 68 (2001) 51-57
11. Mugneret F., Lizard S., Aurias A., and Turc-Carel C. Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). Cancer Genet Cytogenet 32 (1988) 239-245
12. Douglass E.C., Rowe S.T., Valentine M., Parham D., Meyer W.H., and Thompson E.I. A second nonrandom translocation der(16)t(1;16)(q21;q13) in Ewing's sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet 53 (1990) 87-90
13. Hindkjaer J., Hammoudah S.A.F.M., Bendix Hansen K., Jensen P.D., Koch J., and Pedersen B. Translocation (1;16) identified by chromosome painting, and PRimed IN Situ-labeling (PRINS): report of two cases and review of the cytogenetic literature. Cancer Genet Cytogenet 79 (1995) 15-20
14. Hattinger C.M., Rumpler S., Ambros I.M., Strehl S., Lion T., Zoubek A., Gadner H., and Ambros P.F. Demonstration of the translocation der(16)t(1;16)(q12;q11.2) in interphase nuclei of Ewing tumors. Genes Chromosomes Cancer 17 (1996) 141-150
15. Stark B., Mor C., Jeison M., Gobuzov R., Cohen I.J., Goshen Y., Stein J., Fisher S., Ash S., Yaniv I., and Zaizov R. Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors. J Neurooncol 31 (1997) 3-8
16. Day S.J., Nelson M., Rosenthal H., Vergara G.G., and Bridge J.A. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeleatl myxoid chondrosarcoma. Genes Chromosomes Cancer 20 (1997) 425-427
17. Gibas Z., Miettinen M., Limon J., Nedoszytko B., Mrozek K., Roszkiewicz A., Rys J., Niezabitowski A., and Debiec-Rychter M. Cytogenetic and immunohistochemical profile of myxoid liposarcoma. Am J Clin Pathol 103 (1995) 20-26
18. Birch N.C., Antonescu C.R., Nelson M., Sarran L., Neff J.R., Seemayer T., and Bridge J.A. Inconspicuous insertion 22;12 in myxoid/round cell liposarcoma accompanied by the secondary structural abnormality der(16)t(1;16). J Mol Diagn 5 (2003) 191-194
19. Qualman S.J., Bowen J., Parham D.M., Branton P.A., and Meyer W.H. Protocol for the examination of specimens from patients (children and adults) with rhabdomyosarcoma. Arch Pathol Lab Med 127 (2003) 1290-1297
20. Pappo A.S., Shapiro D.N., Crist W.M., and Maurer H.M. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13 (1995) 2123-2139
21. Althof P.A., Ohmori K., Zhou M., Bailey J.M., Bridge R.S., Nelson M., Neff J.R., and Bridge J.A. Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Mod Pathol 17 (2004) 518-525
22. ISCN 1995: an international system for human cytogenetic nomenclature (1995). In: Mitelman F. (Ed) (1995), S. Karger, Basel
23. Nishio J., Althof P.A., Bailey J.M., Zhou M., Neff J.R., Barr F.G., Parham D.M., Teot L., Qualman S.J., and Bridge J.A. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest 86 (2006) 547-556
24. Edwards R.H., Chatten J., Xiong Q.B., and Barr F.G. Detection of gene fusions in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction assay of archival samples. Diagn Mol Pathol 6 (1997) 91-97
25. Mrozek K., and Bloomfield C.D. Der(16)t(1;16) is a secondary chromosome aberration in at least eighteen different types of human cancer. Genes Chromosomes Cancer 23 (1998) 78-80
26. Mrozek K., Arthur D.C., Karakousis C.P., Koduru P.R.K., Le Beau M.M., Pettenati M.J., Tantravahi R., Mrozek E., Perez-Mesa C., Rao U.N.M., Frankel S.R., Davey F.R., and Bloomfield C.D. Der(16)t(1;16) is a nonrandom secondary chromosome aberration in many types of human neoplasia, including myxoid liposarcoma, rhabdomyosarcoma and Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Oncol 6 (1995) 531-538
27. Debiec-Rychter M., Hagemeijer A., and Sciot R. Spindle-cell rhabdomyosarcoma with 2q36-q37 involvement. Cancer Genet Cytogenet 140 (2003) 62-65
28. Forus A., Weghuis D.O., Smeets D., Fodstad O., Myklebost O., and Guerts van Kessel A. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14 (1995) 8-14
29. Forus A., Berner J.M., Meza-Zepeda L.A., Saeter G., Mischke D., Fodstad O., and Myklebost O. Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas. Br J Cancer 78 (1998) 495-503
30. Gordon A.T., Brinkschmidt C., Anderson J., Coleman N., Dockhorn-Dworniczak B., Pritchard-Jones K., and Shipley J. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 28 (2000) 220-226
31. Nilsson M., Meza-Zepeda L.A., Mertens F., Forus A., Myklebost O., and Mandahl N. Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer 109 (2004) 363-369
32. Kresse S.H., Berner J.M., Meza-Zepeda L.A., Gregory S.G., Kuo W.L., Gray J.W., Forus A., and Myklebost O. Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH. Mol Cancer 4 (2005) 39
33. Visser M., Sijmons C., Bras J., Arceci R.J., Godfried M., Valentijn L.J., Voute P.A., and Baas F. Allelotype of pediatric rhabdomyosarcoma. Oncogene 15 (1997) 1309-1314
34. Rakha E.A., Green A.R., Powe D.G., Roylance R., and Ellias I.O. Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer 45 (2006) 527-535
35. Watson J.E.V., Doggett N.A., Albertson D.G., Andaya A., Chinnaiyan A., Van Dekken H., Ginzinger D., Haqq C., James K., Kamkar S., Kowbel D., Pinkel D., Schmitt L., Simko J.P., Volik S., Weinberg V.K., Paris P.L., and Collins C. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene 23 (2004) 3487-3494
36. Toyooka K.O., Toyooka S., Virmani A.K., Sathyanarayana U.G., Euhus D.M., Gilcrease M., Minna J.D., and Gazdar A.F. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung cancers. Cancer Res 61 (2001) 4556-4560